Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Atossa Therapeutics, Inc. (ATOS) vs Cocrystal Pharma, Inc. (COCP)

Atossa Therapeutics, Inc. and Cocrystal Pharma, Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and Cocrystal Pharma, Inc. are of similar size ($22.2M and $20.5M). Cocrystal Pharma, Inc. grew revenue faster over the last twelve months: −30.4% against −93.7%. Atossa Therapeutics, Inc. has the higher net margin (0.00% vs −747.8%) and the lower return on invested capital (−3,918.8% vs 0.00%). Across the 16 metrics below, Atossa Therapeutics, Inc. leads on 8 and Cocrystal Pharma, Inc. on 8.

Valuation

Metric ATOS COCP Biotechnology median
P/E n/m n/m 7.88
P/S 422.12 12.14 11.47
P/B 0.63 15.45 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.24 n/m 0.74
EV/Sales (231.34) 10.46 10.73
Earnings yield (230.65%) (64.96%) (28.84%)
Free cash flow yield (211.50%) (49.38%) (23.03%)

Profitability

Metric ATOS COCP Biotechnology median
Gross margin 0.00% 9.10% 65.16%
Operating margin 0.00% (760.72%) 0.00%
Net margin 0.00% (747.78%) 0.00%
Free cash flow margin 0.00% (598.50%) 0.00%
Return on equity (89.23%) (311.68%) (57.72%)
Return on assets (77.91%) (151.10%) (49.22%)
Return on invested capital (3,918.83%) 0.00% 0.00%

Growth

Metric ATOS COCP Biotechnology median
Revenue growth (TTM) (93.66%) (30.38%) 5.64%
EPS growth (last fiscal year) (34.73%) 54.65% —
Revenue growth, 5-year CAGR — (33.30%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATOS COCP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.69 1.24 4.73
Net debt to EBITDA 1.12 0.82 0.96

Dividend

Metric ATOS COCP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATOS COCP Biotechnology median
Market cap 20.46m 22.15m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack